𧬠Genomics & Biotech Innovation
Gene editing, sequencing, mRNA platforms and AI-driven drug discovery.
| # | Ticker | Name | Charts | Mkt Cap | Price | P/E | Fwd P/E | Ξ P/E | ROCE % | ROA % | Rev CAGR 5Y % | Profit CAGR 5Y % | Div % | 1Y % | Sector |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | $985.37B | 1,105.00 | 39.21 | 24.85 | Ξ 14.36 | 38.44% | 20.74% | 31.69% | 48.96% | 0.63% | +50.86% | Healthcare | |
| 2 | MRK | Merck & Co., Inc. | $293.22B | 118.72 | 33.44 | 12.41 | Ξ 21.03 | 20.66% | 12.58% | 3.12% | 7.93% | 2.86% | +60.12% | Healthcare | |
| 3 | ISRG AI | Intuitive Surgical, Inc. | $150.39B | 424.64 | 51.53 | 36.01 | Ξ 15.52 | 15.96% | 10.24% | 17.39% | 29.26% | - | -23.12% | Healthcare | |
| 4 | PFE | Pfizer Inc. | $149.21B | 26.18 | 19.98 | 9.23 | Ξ 10.76 | 5.95% | 5.69% | -14.80% | -37.20% | 6.57% | +19.24% | Healthcare | |
| 5 | VRTX | Vertex Pharmaceuticals Incorporated | $113.59B | 447.54 | 26.53 | 20.84 | Ξ 5.69 | 21.38% | 12.14% | 10.35% | 5.97% | - | +1.24% | Healthcare | |
| 6 | REGN | Regeneron Pharmaceuticals, Inc. | $64.45B | 614.78 | 15.02 | 11.43 | Ξ 3.58 | 14.57% | 6.13% | 5.62% | 1.26% | 0.61% | +26.08% | Healthcare | |
| 7 | MRNA | Moderna, Inc. | $18.72B | 47.19 | - | - | - | -26.64% | -13.09% | -53.30% | -44.58% | - | +77.67% | Healthcare | |
| 8 | TEM AI | Tempus AI, Inc. | $9.06B | 50.47 | - | - | - | -11.61% | -9.07% | 58.29% | 5.15% | - | -8.54% | Healthcare | |
| 9 | CRSP | CRISPR Therapeutics AG | $5.42B | 56.18 | - | - | - | -31.41% | -14.06% | -33.33% | 3.52% | - | +54.81% | Healthcare | |
| 10 | TWST | Twist Bioscience Corporation | $4.16B | 66.87 | - | - | - | -24.75% | -12.93% | 22.76% | 21.45% | - | +128.23% | Healthcare | |
| 11 | RLAY | Relay Therapeutics, Inc. | $3.06B | 14.05 | - | - | - | -50.82% | -24.72% | 123.20% | 1.61% | - | +368.33% | Healthcare | |
| 12 | NTLA | Intellia Therapeutics, Inc. | $1.97B | 14.07 | - | - | - | -59.74% | -30.14% | 9.09% | 4.32% | - | +104.80% | Healthcare | |
| 13 | RXRX AI | Recursion Pharmaceuticals, Inc. | $1.91B | 3.59 | - | - | - | -48.48% | -27.66% | 23.23% | -56.41% | - | -14.11% | Healthcare | |
| 14 | SDGR | SchrΓΆdinger, Inc. | $1.14B | 15.20 | - | - | - | -31.08% | -14.96% | 12.24% | 10.26% | - | -29.69% | Healthcare | |
| 15 | EDIT | Editas Medicine, Inc. | $530.98M | 3.46 | - | - | - | -109.70% | -26.95% | 27.15% | 9.13% | - | +101.16% | Healthcare | |
| 16 | PACB | Pacific Biosciences of California, Inc. | $462.80M | 1.49 | - | - | - | -75.80% | -11.96% | 7.64% | -24.62% | - | +55.21% | Healthcare | |
| 17 | BEAM | BEAM | - | 32.93 | - | - | - | -27.72% | - | 31.88% | 24.11% | - | +108.02% | - |
Ad space